NCT05416957View on ClinicalTrials.gov

Food Effect Bioavailability Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 18, 2022

Primary Completion Date

October 27, 2022

Study Completion Date

October 27, 2022

Conditions
Major Depressive Disorder (MDD)
Interventions
DRUG

Vortioxetine Hemihydrobromide Orally Disintegrating Tablets

Vortioxetine Hemihydrobromide Orally Disintegrating Tablets 20mg administration under fasting condition

Trial Locations (1)

382210

Cliantha Research Limited, Ahmedabad

All Listed Sponsors
lead

Seasons Biotechnology (Taizhou) Co., Ltd.

INDUSTRY